4.7 Article

Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment

Journal

BRAIN BEHAVIOR AND IMMUNITY
Volume 40, Issue -, Pages 40-47

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2014.02.019

Keywords

Chronic stress; Beta-adrenergic; Pancreatic cancer; Invasion; Beta-blocker; Tumor microenvironment

Funding

  1. Australian National Health and Medical Research Council [1008865, 1049561]
  2. Australian Research Council [LE1 10100125]
  3. National Cancer Institute [CA160890]
  4. Swiss Cancer League
  5. Monash University
  6. Australian Postgraduate Award
  7. Co-operative Research Centre for Cancer Therapeutics
  8. Bern Cancer League
  9. National Breast Cancer Foundation

Ask authors/readers for more resources

Pancreatic cancer cells intimately interact with a complex microenvironment that influences pancreatic cancer progression. The pancreas is innervated by fibers of the sympathetic nervous system (SNS) and pancreatic cancer cells have receptors for SNS neurotransmitters which suggests that pancreatic cancer may be sensitive to neural signaling. In vitro and non-orthotopic in vivo studies showed that neural signaling modulates tumour cell behavior. However the effect of SNS signaling on tumor progression within the pancreatic microenvironment has not previously been investigated. To address this, we used in vivo optical imaging to non-invasively track growth and dissemination of primary pancreatic cancer using an orthotopic mouse model that replicates the complex interaction between pancreatic tumor cells and their microenvironment. Stress-induced neural activation increased primary tumor growth and tumor cell dissemination to normal adjacent pancreas. These effects were associated with increased expression of invasion genes by tumor cells and pancreatic stromal cells. Pharmacological activation of p-adrenergic signaling induced similar effects to chronic stress, and pharmacological beta-blockade reversed the effects of chronic stress on pancreatic cancer progression. These findings indicate that neural p-adrenergic signaling regulates pancreatic cancer progression and suggest beta-blockade as a novel strategy to complement existing therapies for pancreatic cancer. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available